Recall Register

Food, drugs, devices › Abbott Medical

Device recall: Fast-Cath Hemostasis Introducer, HEMOSTASIS INTRODUCER, 8.5F, 2.83 mm, REF 406143 - Product Usage: The Fast-Cath Hemosta

FDA enforcement event 84459 · Class II · initiated 9 Dec 2019 · status Terminated · terminated 11 Dec 2020

DeviceVoluntary: Firm initiated1 product recordPlymouth, MN

FDA enforcement event 84459 is a device recall by Abbott Medical of Plymouth, MN, initiated 9 Dec 2019 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 968 device enforcement events initiated in 2019 carry the same class.

Status: Terminated, terminated 11 Dec 2020. Initiation: voluntary: firm initiated. Abbott Medical has 16 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Abbott Medical, Plymouth, MN.

Reason for recall

"Three lots of Fast-Cath Hemostasis Introducer devices contained 8F sized dilators and sheaths instead of the expected 8.5F devices."

Distribution

"Worldwide distribution - US Nationwide distribution in the states of MA, VA, NH, FL, CT, UT, OH, WI, NY, IA, MI, MS, PA, and countries of Canada, Czech Republic"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0789-2020Fast-Cath Hemostasis Introducer, HEMOSTASIS INTRODUCER, 8.5F, 2.83 mm, REF 406143 - Product Usage: The Fast-Cath Hemostasis Introducers are indicated for the introduction of angiographic catheters, closed-end catheters, balloon catheters, and electrodes into a vessel where minimizing blood loss is essential.380 devicesClass IITerminated15 Jan 2020

Context

88%of 2019 device events are Class II968 events that year
1product record in this eventfirm median: 1
16events on this register for the firm

Other enforcement events for Abbott Medical

InitiatedProduct (first record)TypeClassRecords
12 May 2026Merlin" Patient Care System (PCS) software Merlin" PCS 3650 programmer Model 3330 softwareDeviceClass II1
6 Oct 2025Eterna SCS IPG (Implantable Pulse Generator), Model Number 32400DeviceClass II2
15 Feb 2025Aveir DR Leadless Pacemaker (LP) Ventricular Device REF LSP202V UDI-DI code: 05415067040725 REF LSP112V UDI-DI code: 054DeviceClass II1
21 Nov 2024The Merlin PCS 3650 programmer Model 3330 The Merlin PCS programmer model 3650 is a portable, dedicated programming systDeviceClass II1
17 Oct 2024Abbott Navitor Titan, Vision Technology, Transcatheter Aortic Heart Valve, 35 mm, NVRO-35, SterileDeviceClass II5
1 Oct 2024Merlin@home Transmitter REF EX1100 The Merlin@home" (M@h) transmitter is intended to transfer stored data from the patieDeviceClass III2
22 May 2024Abbott Infinity 5, Implantable Pulse Generator, REF: 6660, SterileEO, Rx OnlyDeviceClass II4
16 May 2024Abbott Liberta RC, Implantable Pulse Generator, REF: 62400, STERILE, RxONLYDeviceClass II1
16 May 2024Abbott Proclaim XR 5 Implantable Pulse Generator, REF 3660, Sterile EO, Rx OnlyDeviceClass II12
5 Feb 2024Abbott Aveir Leadless Pacemaker, REF: LSP112V, STERILEEODeviceClass II1

All 16 events for Abbott Medical

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Three lots of Fast-Cath Hemostasis Introducer devices contained 8F sized dilators and sheaths instead of the expected 8.5F devices."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide distribution - US Nationwide distribution in the states of MA, VA, NH, FL, CT, UT, OH, WI, NY, IA, MI, MS, PA, and countries of Canada, Czech Republic"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 11 Dec 2020. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.